Vanguard Group Inc. lifted its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) by 87.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,478,350 shares of the medical equipment provider’s stock after acquiring an additional 689,954 shares during the quarter. Vanguard Group Inc. owned 3.96% of Lantheus Holdings worth $26,093,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in LNTH. State of Alaska Department of Revenue acquired a new stake in shares of Lantheus Holdings in the second quarter valued at about $102,000. Municipal Employees Retirement System of Michigan acquired a new stake in shares of Lantheus Holdings in the second quarter valued at about $107,000. LS Investment Advisors LLC acquired a new stake in shares of Lantheus Holdings in the second quarter valued at about $112,000. BNP Paribas Arbitrage SA acquired a new stake in shares of Lantheus Holdings in the second quarter valued at about $146,000. Finally, Louisiana State Employees Retirement System acquired a new stake in shares of Lantheus Holdings in the second quarter valued at about $212,000. Hedge funds and other institutional investors own 87.55% of the company’s stock.

Lantheus Holdings, Inc. (NASDAQ:LNTH) opened at $22.25 on Monday. The company has a debt-to-equity ratio of -3.41, a current ratio of 2.96 and a quick ratio of 2.46. The firm has a market cap of $834.51, a PE ratio of 19.87, a PEG ratio of 1.82 and a beta of 0.92. Lantheus Holdings, Inc. has a 52 week low of $7.95 and a 52 week high of $24.10.

Lantheus Holdings (NASDAQ:LNTH) last posted its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.04. The firm had revenue of $79.94 million for the quarter, compared to the consensus estimate of $77.18 million. Lantheus Holdings had a net margin of 9.59% and a negative return on equity of 46.45%. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period last year, the firm posted $0.15 earnings per share. research analysts anticipate that Lantheus Holdings, Inc. will post 1.02 EPS for the current year.

In other news, Director David F. Burgstahler sold 6,000 shares of the firm’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $17.10, for a total value of $102,600.00. Following the transaction, the director now directly owns 13,248 shares of the company’s stock, valued at $226,540.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO John W. Crowley sold 6,755 shares of the firm’s stock in a transaction dated Friday, October 13th. The stock was sold at an average price of $18.41, for a total transaction of $124,359.55. The disclosure for this sale can be found here. Over the last three months, insiders sold 815,160 shares of company stock worth $13,913,347. Insiders own 2.30% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.watchlistnews.com/vanguard-group-inc-grows-stake-in-lantheus-holdings-inc-lnth/1699411.html.

Several brokerages have recently issued reports on LNTH. Zacks Investment Research upgraded shares of Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $26.00 target price on the stock in a research report on Tuesday, November 7th. Credit Suisse Group lifted their target price on shares of Lantheus Holdings from $19.00 to $23.00 and gave the company a “neutral” rating in a research report on Friday, November 3rd. Jefferies Group LLC lifted their target price on shares of Lantheus Holdings from $22.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Wells Fargo & Company upgraded shares of Lantheus Holdings from a “market perform” rating to an “outperform” rating in a research report on Thursday, November 2nd. Finally, Cantor Fitzgerald began coverage on shares of Lantheus Holdings in a research report on Monday, July 17th. They issued an “overweight” rating and a $22.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Lantheus Holdings has a consensus rating of “Buy” and an average target price of $24.50.

About Lantheus Holdings

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).

Institutional Ownership by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.